SignatureFD’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Sell
5,300
-405
-7% -$180K 0.04% 172
2025
Q1
$2.77M Buy
5,705
+656
+13% +$318K 0.05% 141
2024
Q4
$2.03M Sell
5,049
-100
-2% -$40.3K 0.04% 171
2024
Q3
$2.39M Buy
5,149
+55
+1% +$25.6K 0.05% 146
2024
Q2
$2.39M Sell
5,094
-190
-4% -$89.1K 0.05% 138
2024
Q1
$2.21M Buy
5,284
+388
+8% +$162K 0.05% 149
2023
Q4
$1.99M Buy
4,896
+448
+10% +$182K 0.05% 150
2023
Q3
$1.55M Buy
4,448
+308
+7% +$107K 0.04% 172
2023
Q2
$1.46M Buy
4,140
+386
+10% +$136K 0.04% 181
2023
Q1
$1.18M Buy
3,754
+272
+8% +$85.7K 0.03% 210
2022
Q4
$1.01M Buy
3,482
+125
+4% +$36.1K 0.03% 233
2022
Q3
$972K Buy
3,357
+388
+13% +$112K 0.03% 201
2022
Q2
$837K Buy
2,969
+332
+13% +$93.6K 0.03% 233
2022
Q1
$688K Buy
2,637
+330
+14% +$86.1K 0.02% 299
2021
Q4
$507K Buy
2,307
+631
+38% +$139K 0.02% 393
2021
Q3
$304K Sell
1,676
-1,636
-49% -$297K 0.01% 536
2021
Q2
$668K Buy
3,312
+3
+0.1% +$605 0.03% 269
2021
Q1
$711K Buy
3,309
+264
+9% +$56.7K 0.03% 229
2020
Q4
$720K Buy
3,045
+1,044
+52% +$247K 0.03% 193
2020
Q3
$545K Sell
2,001
-36
-2% -$9.81K 0.03% 220
2020
Q2
$591K Buy
2,037
+398
+24% +$115K 0.04% 188
2020
Q1
$390K Buy
1,639
+270
+20% +$64.2K 0.03% 236
2019
Q4
$300K Buy
1,369
+143
+12% +$31.3K 0.02% 362
2019
Q3
$208K Buy
1,226
+210
+21% +$35.6K 0.02% 396
2019
Q2
$186K Buy
1,016
+72
+8% +$13.2K 0.02% 417
2019
Q1
$174K Sell
944
-8
-0.8% -$1.48K 0.01% 433
2018
Q4
$158K Buy
952
+191
+25% +$31.7K 0.01% 433
2018
Q3
$147K Buy
761
+22
+3% +$4.25K 0.01% 511
2018
Q2
$126K Sell
739
-62
-8% -$10.6K 0.01% 533
2018
Q1
$131K Buy
+801
New +$131K 0.02% 447
2016
Q4
Sell
-453
Closed -$40K 1205
2016
Q3
$40K Buy
453
+126
+39% +$11.1K 0.01% 593
2016
Q2
$28K Buy
327
+22
+7% +$1.88K ﹤0.01% 634
2016
Q1
$24K Buy
305
+54
+22% +$4.25K ﹤0.01% 617
2015
Q4
$32K Buy
251
+173
+222% +$22.1K 0.01% 454
2015
Q3
$8K Buy
78
+68
+680% +$6.97K ﹤0.01% 740
2015
Q2
$1K Buy
+10
New +$1K ﹤0.01% 995